Overview

Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants

Status:
COMPLETED
Trial end date:
2025-04-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of SUZ on the pharmacokinetics of oral contraceptives.
Phase:
PHASE1
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated